Drug Shortage Report for BURINEX
Report ID | 185280 |
Drug Identification Number | 00728276 |
Brand name | BURINEX |
Common or Proper name | BURINEX TAB 5 MG |
Company Name | KARO PHARMA AB |
Market Status | MARKETED |
Active Ingredient(s) | BUMETANIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | C03CA |
ATC description | HIGH-CEILING DIURETICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-12-05 |
Estimated end date | |
Actual end date | 2023-04-23 |
Shortage status | Resolved |
Updated date | 2023-04-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | KLARA NORRA KYRKOGATA 33 STOCKHOLM, -- SWEDEN 11122 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-04-24 | French | Compare |
v5 | 2023-04-03 | French | Compare |
v4 | 2023-04-03 | English | Compare |
v3 | 2023-02-22 | French | Compare |
v2 | 2023-02-22 | English | Compare |
v1 | 2023-02-22 | English | Compare |
Showing 1 to 6 of 6